Skip to content

A study to evaluate efficacy and safety of Anti-pollution product.

A clinical study to evaluate the protective effect of the test product against environmental pollution on the skin along with its safety on healthy adult female subjects. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/072157
Enrollment
36
Registered
2024-08-08
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Face Wash: Approx. 1 – 1.5 gm of product will be applied twice a day Control Intervention1: NIL: NIL

Sponsors

Zydus Wellness Products Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Subjects who have lived in high air pollution areas for at least the past 5 years / have been occupationally exposed to high air pollution for the past 2 years. 2) Subjects with visible blackheads on the face. 3) Subjects with at least 2 blemishes, uneven skin tone and visible redness on face. 4) Subjects willing to provide written informed consent to participate in the study.

Exclusion criteria

Exclusion criteria: 1) Subjects using any other face wash during the study period. 2) Subjects who are receiving topical or systemic treatments for pigmentation within the last 30 days. 3) Subjects having any active dermatological skin diseases (e.g., psoriasis, atopic dermatitis, rosacea etc.), that might interfere with clinical assessments. 4) Subjects participating in other similar cosmetic or therapeutic study within last four weeks.

Design outcomes

Primary

MeasureTime frame
To assess the efficacy of test product on pollution-induced skin damages, based on clinical, instrumental and subjective evaluations done at predetermined time points.Timepoint: Day 01, Day 07, Day 14, Day 21 and Day 28.

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Parth Joshi

Cliantha Research

ssethi@cliantha.com9825784942

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026